Details:
Based on new IP (intellectual property), the scope of the collaboration agreement has expanded to include a new patent family covering innovative new AKVANO® topical formulations.
Lead Product(s): Cannabidiol
Therapeutic Area: Dermatology Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Small molecule
Partner/Sponsor/Collaborator: Cannassure Therapeutics
Deal Size: $0.4 million Upfront Cash: Undisclosed
Deal Type: Expanded Collaboration October 29, 2021